Physician profile
Jason Lowery
NPI 1700049525
$1,363.99
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $215 · 2021: $87.43 · 2022: $552 · 2024: $99.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $274.79 | 2022 | |
| Novo Nordisk INC | $258.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $158.14 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $143.71 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $72.81 | 2019-2022 | |
| Glaxosmithkline, LLC. | $72.00 | 2019-2021 | |
| Pfizer INC. | $65.24 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.12 | 2022 | |
| Nevro Corp. | $57.53 | 2019 | |
| Allergan, INC. | $48.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.49 | 2020-2022 | |
| Abbott Laboratories | $24.45 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.17 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.01 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.53 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.